<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Endothelial markers endothelin 1 (ET-1) and <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (vWF) were assessed in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> and in patients with <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: In this case-control study, plasma ET-and vWF levels were measured by enzyme-linked immunosorbent assay in 35 normoalbuminuric type 2 diabetic patients with <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> (56+/-5 years), in 21 nondiabetic patients with <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> (52+/-7 years), and in 19 healthy control subjects (45+/-4 years) </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> of the individuals were normotensive and nonsmokers </plain></SENT>
<SENT sid="3" pm="."><plain>Urinary albumin was measured by immunoturbidimetry </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: ET-1 levels were higher (P&lt;0.0001) in type 2 diabetic dyslipidemic patients (1.62+/-0.73 pg/ml) than in both nondiabetic hypercholesterolemic patients (0.91+/-0.73 pg/ml) and control subjects (0.69+/-0.25 pg/ml) </plain></SENT>
<SENT sid="5" pm="."><plain>vWF levels were significantly increased (P = 0.02) in type 2 diabetic (185.49+/-72.1%) and hypercholesterolemic (163.29+/-50.7%) patients compared with control subjects (129.70+/-35.2%) </plain></SENT>
<SENT sid="6" pm="."><plain>In the multiple linear regression analysis </plain></SENT>
<SENT sid="7" pm="."><plain>ET-1 was significantly associated (adjusted r2 = 0.42) with serum <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels (P&lt;0.001), age (P&lt;0.01), insulin sensitivity index (P&lt;0.02), and <z:mp ids='MP_0002871'>albuminuria</z:mp> levels (P&lt;0.04) </plain></SENT>
<SENT sid="8" pm="."><plain>vWF levels were associated (adjusted r2 = 0.22) with <z:mp ids='MP_0002871'>albuminuria</z:mp> (P&lt;0.001), fibrinogen levels (P&lt;0.02), and BMI (P&lt;0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Compared with hypercholesterolemic patients, type 2 diabetic patients with <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> have increased levels of ET-1 and vWF which may indicate more pronounced endothelial injury </plain></SENT>
<SENT sid="10" pm="."><plain>These findings appear to be related to components of the <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> syndrome </plain></SENT>
</text></document>